Trial intelligence / Profile preview

SAMBA: Cerebral Autoregulation with Propofol vs Sevoflurane

NCT03816072Completed

Sponsor
University of Amsterdam
Start
Jan 2019
Primary completion
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of propofol injection (veterinary) and sevoflurane (2 arms), sponsored by University of Amsterdam. Primary endpoints: Changes in dynamic cerebral autoregulation and Differences in dynamic cerebral autoregulation between sevoflurane and propofol. Started Jan 2019; status: completed.

02

Drugs

propofol injection (veterinary)sevoflurane

Beyond the preview

Go deeper on NCT03816072.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03816072.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call